ERBB2 and triple-negative breast carcinoma: Triple-negative breast cancer (TNBC) is characterized by the absence of estrogen and progesterone hormone receptor expression in tumor cells, and the lack of human epidermal growth factor receptor 2 (HER2) growth factor expression on immunohistochemistry.